Yohimbine HCL Powder

Description Yohimbine HCL CAS Number 146-48-5 Molar Mass 354.44 g/mol Chemical Formula C21H26N2O3 IUPAC Name 17α-hydroxyyohimban-16α-carboxylic acid methyl ester Introduction Yohimbine HCL, a chemical compound derived from the bark of the Pausinystalia yohimbe tree, is a research substance gaining attention for its potential applications in various scientific fields. While its traditional use has been associated with conventional medicine, its research potential is primarily centered around its impact on weight loss and memory, and its potential implications for diabetes research. Key Characteristics Yohimbine HCL is characterized by its adrenergic antagonist properties, particularly its ability to block alpha-2 adrenergic receptors. This characteristic has led to investigations into its effects on metabolic processes, cognitive functions, and its potential benefits for diabetes-related studies. Research Applications Researchers are actively exploring the applications of Yohimbine HCL in various domains. From its potential role in weight loss interventions to its impact on cognitive processes, Yohimbine HCL is a subject of interest for those delving into the intricacies of adrenergic receptor modulation. Research Benefits Yohimbine HCL and Weight Loss Studies have suggested that Yohimbine HCL may have a role in promoting weight loss by influencing the activity of adrenergic receptors, leading to increased lipolysis and energy expenditure. Researchers are delving into its mechanisms and potential applications in weight management. Yohimbine HCL and Memory Preliminary research has explored the effects of Yohimbine HCL on cognitive processes, including memory. Investigations aim to uncover whether its adrenergic modulation properties could contribute to cognitive enhancement. Yohimbine HCL and Diabetes Some studies have suggested a potential link between Yohimbine HCL and improved insulin sensitivity. Research in this area is ongoing to understand the compound’s impact on glucose metabolism and its potential as an adjunct in diabetes-related studies. Summary Yohimbine HCL, with its adrenergic antagonist properties, is a compound under scrutiny for its potential benefits in weight management, cognitive function, and diabetes research. As researchers delve into its mechanisms and applications, Yohimbine HCL remains a focal point in various scientific investigations. Disclaimer This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE. Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the Institutional Animal Care and Use Committee (IACUC) directives, adhering to the standards delineated by the Animal Welfare Act (AWA). Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before making purchasing decisions. Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer satisfaction is our top priority. Should you find any dissatisfaction with the product received, please contact us at 419-707-5450 or email our support team at [email protected]. IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization. References Ostojic SM. Yohimbine: the effects on body composition and exercise performance in soccer players. Res Sports Med. 2006 Oct-Dec;14(4):289-99. doi: 10.1080/15438620600987106. PMID: 17214405. [Read More]. O’Carroll RE, Drysdale E, Cahill L, Shajahan P, Ebmeier KP. Stimulation of the noradrenergic system enhances memory, while blockade reduces it in humans. Psychol Med. 1999 Sep;29(5):1083-8. doi: 10.1017/s0033291799008703. PMID: 10576300. [Read More]. Sandberg M, Pettersson U, Henriksnäs J, Jansson L. The α2-adrenoceptor antagonist yohimbine normalizes increased islet blood flow in GK rats: a model of type 2 diabetes. Horm Metab Res. 2013 Mar;45(3):252-4. doi: 10.1055/s-0032-1323843. Epub 2012 Sep 26. PMID: 23015611. [Read More].